HomeRLAY • NASDAQ
add
Relay Therapeutics Inc
Previous close
$3.27
Day range
$3.09 - $3.48
Year range
$3.02 - $10.72
Market cap
580.82M USD
Avg Volume
1.78M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 0.00 | 100.00% |
Operating expense | 20.55M | 0.76% |
Net income | -76.00M | 8.97% |
Net profit margin | — | — |
Earnings per share | -0.45 | 32.84% |
EBITDA | -83.64M | 9.95% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 781.32M | 4.16% |
Total assets | 871.30M | 3.24% |
Total liabilities | 93.50M | 1.66% |
Total equity | 777.79M | — |
Shares outstanding | 169.52M | — |
Price to book | 0.70 | — |
Return on assets | -23.59% | — |
Return on capital | -24.78% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -76.00M | 8.97% |
Cash from operations | -57.87M | 35.12% |
Cash from investing | 29.00M | -51.41% |
Cash from financing | 800.00K | -96.35% |
Net change in cash | -28.07M | -269.73% |
Free cash flow | -32.94M | 43.09% |
About
Founded
2015
Website
Employees
261